• 1. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

Comprehensive Overview of tert-Butyl 3,3-difluoro-1,8-diazaspiro[4.5]decane-8-carboxylate (CAS No. 1250999-05-3)

tert-Butyl 3,3-difluoro-1,8-diazaspiro[4.5]decane-8-carboxylate (CAS No. 1250999-05-3) is a highly specialized spirocyclic compound that has garnered significant attention in the field of pharmaceutical intermediates and organic synthesis. This compound belongs to the class of diazaspiro derivatives, which are known for their unique structural properties and versatile applications in drug discovery. The presence of difluoro and tert-butyl carboxylate groups enhances its reactivity, making it a valuable building block for medicinal chemistry and bioconjugation.

In recent years, the demand for spirocyclic compounds like tert-Butyl 3,3-difluoro-1,8-diazaspiro[4.5]decane-8-carboxylate has surged due to their role in developing targeted therapies and small molecule inhibitors. Researchers are particularly interested in its potential applications in central nervous system (CNS) drug development, as the diazaspiro scaffold is often associated with improved blood-brain barrier penetration. This aligns with the growing focus on neurodegenerative diseases and psychiatric disorders, which are among the most searched topics in pharmaceutical research.

The synthesis of tert-Butyl 3,3-difluoro-1,8-diazaspiro[4.5]decane-8-carboxylate involves sophisticated organic transformations, including fluorination and carboxylation steps. Its CAS No. 1250999-05-3 serves as a unique identifier, ensuring precise tracking in chemical databases and regulatory submissions. The compound's stability under various conditions makes it suitable for high-throughput screening and combinatorial chemistry, addressing the need for efficient drug candidate optimization.

From an SEO perspective, queries related to "diazaspiro derivatives," "fluorinated spirocycles," and "tert-butyl carboxylate applications" are trending in scientific literature and patent searches. This reflects the compound's relevance in cutting-edge research, particularly in kinase inhibitor design and GPCR-targeted drugs. Additionally, its spiro[4.5]decane core is frequently discussed in forums focusing on 3D molecular modeling and fragment-based drug discovery.

In conclusion, tert-Butyl 3,3-difluoro-1,8-diazaspiro[4.5]decane-8-carboxylate (CAS No. 1250999-05-3) represents a pivotal chemical entity in modern drug development. Its structural complexity and functional groups offer unparalleled opportunities for lead compound refinement and therapeutic innovation. As the pharmaceutical industry continues to explore novel scaffolds, this compound is poised to play a critical role in addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)